Literature DB >> 11728765

Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center.

J R Miner1, W Heegaard, A Mapes, M Biros.   

Abstract

Our objective was to analyze the presentation, time to antibiotics, treatment, and mortality of patients with bacterial meningitis at a large urban county hospital over a 10-year period. A retrospective chart review of all patients with the diagnosis of bacterial meningitis was done. Information concerning presentation, etiologic organisms, treatment (including time to antibiotics), and outcomes were collected and analyzed. There were 165 charts reviewed with 171 total cases of bacterial meningitis. For adults with community-acquired meningitis, the mortality rate was 14%, for children it was 1.6%. Seventy-six percent of patients received antibiotics in the Emergency Department (ED) with a mean time to antibiotics of 1:08 h +/- 13 min. The rest received them as inpatients with a mean time to antibiotics of 6 +/- 9 h. The mortality rate for patients with community-acquired disease who received an Emergency Department antibiotic was 7.9%; for patients who received their antibiotics as inpatients the mortality rate was 29%. Our results indicate that the mortality rates from bacterial meningitis at our institution are lower than previously published results. Furthermore, our study supports the concept that the early administration of antibiotics in the ED may reduce mortality and may be an explanation of the lower mortality rates seen here.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728765     DOI: 10.1016/s0736-4679(01)00407-3

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  34 in total

Review 1.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors:  Bryan T Alexander; Lindsay M Hladnik; Kristan M Augustin; Ed Casabar; Peggy S McKinnon; Richard M Reichley; David J Ritchie; Peter Westervelt; Erik R Dubberke
Journal:  Pharmacotherapy       Date:  2010-06       Impact factor: 4.705

3.  Preclinical Assessment of a Fully Automated Multiplex PCR Panel for Detection of Central Nervous System Pathogens.

Authors:  K E Hanson; E S Slechta; J A Killpack; C Heyrend; T Lunt; J A Daly; A C Hemmert; A J Blaschke
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

4.  Incidence and outcome of pneumococcal meningitis in northern England.

Authors:  N C Weightman; J Sajith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

5.  Early antimicrobial therapy in severe sepsis and septic shock.

Authors:  Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

6.  Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock.

Authors:  John D Dickinson; Marin H Kollef
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

7.  Investigation of the Selection and Timing of Pharmacological Therapy in Community-Acquired Bacterial Meningitis.

Authors:  Jared Sheley; Dave Willman; Julie Downen; Scott Bergman
Journal:  P T       Date:  2016-07

8.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.

Authors:  Zechariah Franks; Robert A Campbell; Adriana Vieira de Abreu; Jeffrey T Holloway; James E Marvin; Bjoern F Kraemer; Guy A Zimmerman; Andrew S Weyrich; Matthew T Rondina
Journal:  Thromb Haemost       Date:  2013-01-24       Impact factor: 5.249

10.  The GRADE system for rating clinical guidelines.

Authors:  Brian P Kavanagh
Journal:  PLoS Med       Date:  2009-09-15       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.